A new study in cats with a fatal coronavirus infection suggests stem cell therapy could help tackle the immune damage behind ...

Fewer than half of eligible patients with advanced ovarian cancer receive first-line maintenance treatments, highlighting ...

Dr. Iwasaki is internationally recognized for her groundbreaking research on viral pathogenesis, human immunobiology, and post-viral chronic conditions, including Long COVID and COVID-19 ...

Life in Tahoe brings endless opportunities to enjoy the outdoors. While time spent in nature benefits our well-being, ...

The EU approves belantamab mafodotin combinations, enhancing treatment options for relapsed multiple myeloma patients with ...

A Chinese man with no medical training is injecting cancer patients with a toxic bleach solution; a full course of treatment ...

The strain that H.R. 1 will put on Washington’s health care system will affect access for the entire region. There is no ...

BioMarin Pharmaceuticals is one of many biotech companies that’s laid off workers over the past two years. Its office in ...

Realty Income (NYSE: O) and Alexandria Real Estate Equities (NYSE: ARE) are two reliable dividend payers that offer an ...

Brazil is scrambling to avert punishing 50% U.S. tariffs in a week's time, but high level talks are stalled and U.S.

Xuewu Liu, a Chinese inventor who has no medical training or credentials of any kind, is charging cancer patients $20,000 for ...

A study from Fred Hutch Cancer Center finds that some cancer patients' antibodies can boost their response to immunotherapy treatment.